Tenascin in Meningioma: Expression Is Correlated with Anaplasia, Vascular Endothelial Growth Factor Expression, and Peritumoral Edema But Not with Tumor Border Shape-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tenascin in Meningioma: Expression Is Correlated with Anaplasia, Vascular Endothelial Growth Factor Expression, and Peritumoral Edema But Not with Tumor Border Shape

Published:2002-07-01 Issue:1 Volume:51 Page:183-194
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:

Author:

Kılıç Türker¹,Bayri Yaşar¹,Özduman Koray¹,Acar Melih¹,Diren Semin²,Kurtkaya Özlem²,Ekinci Gazanfer³,Buğra Kuyaş⁴,Sav Aydın²,Özek M. Memet¹,Pamir M. Necmettin¹

Affiliation:

1. Neurooncology Laboratories, Institute of Neurological Sciences, Marmara University, Istanbul, Turkey

2. Pathology Laboratories, Institute of Neurological Sciences, Marmara University, Istanbul, Turkey

3. Department of Radiology, Marmara University, Istanbul, Turkey

4. Department of Molecular Biology, Boğaziçi University, Istanbul, Turkey

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Clinical Neurology,Surgery

Link

http://academic.oup.com/neurosurgery/article-pdf/51/1/183/24740332/00006123-200207000-00026.pdf

Reference82 articles.

1. Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy;Akabani;Int J Radiat Oncol Biol Phys,2000

2. The extracellular matrix molecule tenascin-C: Expression in vivo and functional characterization in vitro;Bartsch;Prog Neurobiol,1996

3. αvβ3 and αvβ5 integrin expression in meningiomas;Bello;Neurosurgery,2000

4. Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F(ab′)2: A preliminary report;Bigner;J Neurooncol,1995

5. Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results;Bigner;J Clin Oncol,1998

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Long and Winding Road: An Overview of the Immunological Landscape of Intracranial Meningiomas;Cancers;2022-07-26

2. Meningioma Tumor Microenvironment;Advances in Experimental Medicine and Biology;2020

3. Current decision-making in meningiomas;Meningiomas, Part I;2020

4. Meningiomas Display a Specific Immunoexpression Pattern in a Rostrocaudal Gradient: An Analysis of 366 Patients;World Neurosurgery;2019-03

5. Pathogenesis of peri-tumoral edema in intracranial meningiomas;Neurosurgical Review;2017-08-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3